Atossa Therapeutics
ATOS
#9316
Rank
NZ$0.16 B
Marketcap
NZ$1.27
Share price
3.82%
Change (1 day)
-28.18%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): NZ-$0.42

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$0.43. In 2024 the company made an earnings per share (EPS) of NZ-$0.35 an increase over its 2023 EPS that were of NZ-$0.42.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.4220.35%
2024NZ-$0.35-16.67%
2023NZ-$0.4214.29%
2022NZ-$0.3716.67%
2021NZ-$0.31-90.86%
2020NZ-$3.42-2.96%
2019NZ-$3.53-63.09%
2018NZ-$9.56-49.63%
2017NZ-$18.98-57.87%
2016NZ-$45.06-74.01%
2015NZ-$173.34-9.18%
2014NZ-$190.87-12.86%
2013NZ-$219.0370.73%
2012NZ-$128.2934.08%
2011NZ-$95.68263.47%
2010NZ-$26.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.15-4,275.76%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.82-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$15.02-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.37-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.53 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA